圣湘生物科技股份有限公司董事会薪酬与考核委员会关于公司2025年限制性股票激励计划激励对象名单的审核意见及公示情况说明

Core Viewpoint - The company has approved the 2025 Restricted Stock Incentive Plan and has publicly disclosed the list of incentive recipients, ensuring compliance with relevant regulations and confirming the qualifications of the selected individuals [1][5][7]. Disclosure and Verification - The company disclosed the 2025 Restricted Stock Incentive Plan and related documents on the Shanghai Stock Exchange website on July 12, 2025 [1]. - The public notice period for the proposed incentive recipients lasted 10 days, from July 14 to July 23, 2025, during which employees could provide feedback [2]. - No objections were received regarding the proposed incentive recipients by the end of the public notice period [3]. Verification Process - The Board's Compensation and Assessment Committee verified the incentive recipient list, including checking identification documents and employment contracts [4]. - The committee confirmed that all individuals listed as incentive recipients meet the qualifications set forth by the Company Law and other relevant regulations [5]. - The committee also ensured that none of the proposed recipients fell under disqualifying conditions outlined in the management regulations [6][7]. Eligibility Criteria - The incentive recipients are core employees from the wholly-owned subsidiary, Zhongshan Shengxiang Haiji Biomedical Co., Ltd., and do not include independent directors, supervisors, or major shareholders [7].